BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25060522)

  • 21. Oncogenic Ras/ERK signaling activates CDCP1 to promote tumor invasion and metastasis.
    Uekita T; Fujii S; Miyazawa Y; Iwakawa R; Narisawa-Saito M; Nakashima K; Tsuta K; Tsuda H; Kiyono T; Yokota J; Sakai R
    Mol Cancer Res; 2014 Oct; 12(10):1449-59. PubMed ID: 24939643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of regulator of G protein signaling 11 promotes cell migration and associates with advanced stages and aggressiveness of lung adenocarcinoma.
    Yang SH; Li CF; Chu PY; Ko HH; Chen LT; Chen WW; Han CH; Lung JH; Shih NY
    Oncotarget; 2016 May; 7(21):31122-36. PubMed ID: 27105500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and phenotypic characterization of colorectal cancer stem cells with organ-specific metastatic potential.
    Gao W; Chen L; Ma Z; Du Z; Zhao Z; Hu Z; Li Q
    Gastroenterology; 2013 Sep; 145(3):636-46.e5. PubMed ID: 23747337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ADAM9 silencing inhibits breast tumor cell invasion in vitro.
    Micocci KC; Martin AC; Montenegro Cde F; Durante AC; Pouliot N; Cominetti MR; Selistre-de-Araujo HS
    Biochimie; 2013 Jul; 95(7):1371-8. PubMed ID: 23499592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circular RNA circ_0020123 promotes non-small cell lung cancer progression by acting as a ceRNA for miR-488-3p to regulate ADAM9 expression.
    Wan J; Hao L; Zheng X; Li Z
    Biochem Biophys Res Commun; 2019 Jul; 515(2):303-309. PubMed ID: 31153639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of Trask protein interactions in brain metastatic cohorts of lung cancers.
    Wu H; Shang LQ; Chen RL; Yang SM; Wang SL; Wang J; Sun G
    Tumour Biol; 2015 Jun; 36(6):4181-7. PubMed ID: 25775948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma.
    Oria VO; Lopatta P; Schmitz T; Preca BT; Nyström A; Conrad C; Bartsch JW; Kulemann B; Hoeppner J; Maurer J; Bronsert P; Schilling O
    Mol Oncol; 2019 Feb; 13(2):456-479. PubMed ID: 30556643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of disintegrin-metalloproteinase ADAM9 in gastric cancer progression.
    Kim JM; Jeung HC; Rha SY; Yu EJ; Kim TS; Shin YK; Zhang X; Park KH; Park SW; Chung HC; Powis G
    Mol Cancer Ther; 2014 Dec; 13(12):3074-85. PubMed ID: 25344581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ADAM9/WISP-1 axis cooperates with osteoblasts to stimulate primary prostate tumor growth and metastasis.
    Chang AC; Lin LW; Chen YC; Chen PC; Liu SC; Tai HC; Wu HC; Sung SY; Lin TH; Tang CH
    Int J Biol Sci; 2023; 19(3):760-771. PubMed ID: 36778124
    [No Abstract]   [Full Text] [Related]  

  • 30. Tumor invasion induced by oxidative stress is dependent on membrane ADAM 9 protein and its secreted form.
    Mongaret C; Alexandre J; Thomas-Schoemann A; Bermudez E; Chéreau C; Nicco C; Goldwasser F; Weill B; Batteux F; Lemare F
    Int J Cancer; 2011 Aug; 129(4):791-8. PubMed ID: 21064090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced miR-3127-5p expression promotes NSCLC proliferation/invasion and contributes to dasatinib sensitivity via the c-Abl/Ras/ERK pathway.
    Sun Y; Chen C; Zhang P; Xie H; Hou L; Hui Z; Xu Y; Du Q; Zhou X; Su B; Gao W
    Sci Rep; 2014 Oct; 4():6527. PubMed ID: 25284075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stabilization of ADAM9 by N-α-acetyltransferase 10 protein contributes to promoting progression of androgen-independent prostate cancer.
    Lin YW; Wen YC; Chu CY; Tung MC; Yang YC; Hua KT; Pan KF; Hsiao M; Lee WJ; Chien MH
    Cell Death Dis; 2020 Jul; 11(7):591. PubMed ID: 32719332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pleiotropic roles of ADAM9 in the biology of solid tumors.
    Oria VO; Lopatta P; Schilling O
    Cell Mol Life Sci; 2018 Jul; 75(13):2291-2301. PubMed ID: 29550974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motility.
    Benes CH; Poulogiannis G; Cantley LC; Soltoff SP
    Oncogene; 2012 Feb; 31(5):653-63. PubMed ID: 21725358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA‑543 inhibits proliferation, invasion and induces apoptosis of glioblastoma cells by directly targeting ADAM9.
    Ji T; Zhang X; Li W
    Mol Med Rep; 2017 Nov; 16(5):6419-6427. PubMed ID: 28849046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ubiquitin-specific peptidase 39 promotes human glioma cells migration and invasion by facilitating ADAM9 mRNA maturation.
    Xiao Y; Ma W; Hu W; Di Q; Zhao X; Ma X; Chen X; Sun P; Wu H; Wu Z; Chen W
    Mol Oncol; 2022 Jan; 16(2):388-404. PubMed ID: 33811456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HOXB9 enhances the ability of lung cancer cells to penetrate the blood-brain barrier.
    Zheng H; Li C; Li Z; Zhu K; Bao H; Xiong J; Liang P
    Aging (Albany NY); 2020 Dec; 13(4):4999-5019. PubMed ID: 33411683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidative stress induces ADAM9 protein expression in human prostate cancer cells.
    Sung SY; Kubo H; Shigemura K; Arnold RS; Logani S; Wang R; Konaka H; Nakagawa M; Mousses S; Amin M; Anderson C; Johnstone P; Petros JA; Marshall FF; Zhau HE; Chung LW
    Cancer Res; 2006 Oct; 66(19):9519-26. PubMed ID: 17018608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sp1-mediated microRNA-182 expression regulates lung cancer progression.
    Yang WB; Chen PH; Hsu T; Fu TF; Su WC; Liaw H; Chang WC; Hung JJ
    Oncotarget; 2014 Feb; 5(3):740-53. PubMed ID: 24519909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.